NCT07263438
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07263438
Title Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial (Phenix)
Acronym Phenix
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Hospitalier Universitaire Vaudois
Indications
Therapies
Age Groups: adult | senior
Covered Countries CHE


No variant requirements are available.